This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Xufang Guan - Innovator in Epothilones Separation Technologies
Introduction
Xufang Guan is a noted inventor based in Taizhou, China, recognized for his contributions to the field of pharmaceutical sciences. With an impressive portfolio that includes one patent, his work focuses on innovative methods that enhance the separation and purification of valuable compounds.
Latest Patents
Xufang Guan holds a patent titled "Method for the separation and purification of epothilones." This invention discloses a novel technique that specifically targets the separation and purification of epothilones B and A. The method utilizes normal phase silica gel chromatography, where the process involves dissolving the sample containing epothilones B and A with C-Calkyl halide compounds or mixing the sample with silica gel. By gradient eluting the silica gel column using an elution solvent, Guan’s innovative method allows for the efficient isolation of these important pharmaceutical compounds.
Career Highlights
Currently, Xufang Guan is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His work there focuses on developing streamlined processes that advance drug formulation and delivery, thereby contributing significantly to the company’s innovative pursuits in medicine.
Collaborations
Throughout his career, Xufang Guan has collaborated with other notable professionals, including Jidong Wang and Hui Zhang. These partnerships reflect a commitment to teamwork and the sharing of ideas that drive innovation within the pharmaceutical sector.
Conclusion
Xufang Guan stands out as an influential inventor whose work in the separation and purification of epothilones has the potential to impact the pharmaceutical industry significantly. His dedication to innovation and collaboration positions him as a valuable asset in the ongoing quest to enhance drug development processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile